MDGL Stock Soars 11% on New Patent Protecting Rezdiffra Dosing Rights

• click to rate

  Posted by Two Blokes Jul 17 - Filed in Stock - 2 views
  
  Madrigal Pharmaceuticals stock jumps 11% after securing a new U.S. patent for Rezdiffra's dosing, reinforcing exclusivity through 2044.